Clinical Study
n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes
Table 2
Kinetic parameters of apoB-48 in TRL and apoB-100 in VLDL following supplementation with n-3 PUFA in patients with type 2 diabetes.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PUFA: polyunsaturated fatty acid. TRL: triglyceride-rich lipoproteins. Mean ± SD; % represents the percentage of difference between the two intervention phases. |